The FBP1 activators represent a class of compounds that modulate the activity of Fructose-1,6-bisphosphatase 1 (FBP1), a critical enzyme involved in glucose metabolism. FBP1 is a key regulatory enzyme in gluconeogenesis, a metabolic pathway responsible for the synthesis of glucose from non-carbohydrate precursors. Its predominant function occurs in the liver and kidneys, where it catalyzes the hydrolysis of fructose-1,6-bisphosphate to fructose-6-phosphate, a crucial step in inhibiting glucose production. This process is especially significant during fasting or periods of low glucose availability when the body requires a means to generate glucose for energy. The role of FBP1 in maintaining glucose homeostasis is pivotal for overall metabolic health. By controlling the rate-limiting step in gluconeogenesis, FBP1 acts as a metabolic switch that regulates glucose production in response to nutritional and physiological cues. During times of energy surplus, FBP1 activity is inhibited, allowing glycolysis to prevail and promoting the utilization of glucose for energy.
The activation of FBP1 involves complex molecular mechanisms that integrate signals from various cellular pathways. FBP1 activity is allosterically regulated by its substrate, fructose-1,6-bisphosphate, which promotes an active conformation of the enzyme. Additionally, post-translational modifications, such as phosphorylation, can modulate FBP1 activity in response to intracellular signaling events. The phosphorylation status of FBP1 is influenced by the activity of protein kinases and phosphatases, which respond to cellular energy levels and hormonal signals. The intricate regulatory network governing FBP1 underscores its importance as a metabolic rheostat that can be finely tuned to meet the dynamic energy demands of the cell. Understanding the general mechanisms of FBP1 activation sheds light on the intricate control of glucose metabolism, providing insights into the broader landscape of cellular bioenergetics.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which in turn can enhance gluconeogenesis and potentially upregulate FBP1 activity. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, can indirectly stimulate FBP1 by mimicking cAMP's role in gluconeogenesis. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
(-)-Epinephrine boosts cAMP levels, indirectly stimulating FBP1 through the activation of gluconeogenesis. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can upregulate gluconeogenesis, potentially increasing FBP1 activity as part of this metabolic pathway. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
1,1-Dimethylbiguanide, Hydrochloride can influence gluconeogenic pathways, potentially affecting FBP1 activity indirectly. | ||||||
Glycerol | 56-81-5 | sc-29095A sc-29095 | 100 ml 1 L | $56.00 $153.00 | 12 | |
As a gluconeogenic substrate, glycerol can indirectly enhance FBP1 activity by being part of the pathway FBP1 regulates. | ||||||
Pyruvic acid | 127-17-3 | sc-208191 sc-208191A | 25 g 100 g | $41.00 $96.00 | ||
Pyruvic acid, another key gluconeogenic substrate, can indirectly influence FBP1 activity through its role in gluconeogenesis. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a beta-adrenergic agonist, increases cAMP and can thereby indirectly activate FBP1 by promoting gluconeogenesis. | ||||||
Theophylline | 58-55-9 | sc-202835 sc-202835A sc-202835B | 5 g 25 g 100 g | $20.00 $32.00 $85.00 | 6 | |
Theophylline increases cAMP levels by inhibiting phosphodiesterase, which can indirectly stimulate FBP1 activity through enhanced gluconeogenesis. | ||||||
D-Glucose 6-phosphate disodium salt | 3671-99-6 | sc-221488 sc-221488A sc-221488B | 10 mg 1 g 25 g | $39.00 $67.00 $1124.00 | 1 | |
D-Glucose 6-phosphate disodium salt is a key regulator in gluconeogenesis and can influence FBP1 activity indirectly through feedback mechanisms. | ||||||